LC
WGS icon

Lindbrook Capital’s GeneDx Holdings WGS Stock Holding History

Lindbrook Capital’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$3.45K Buy
39
+23
+144% +$2K ﹤0.01% 2103
2024
Q4 		$1.23K Buy
16
+7
+78% +$489 ﹤0.01% 2441
2024
Q3 		$382 Hold
9
– – ﹤0.01% 2726
2024
Q2 		$235 Buy
+9
New +$171 ﹤0.01% 2694

Other funds holding WGS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Lindbrook Capital's WGS Position: Q1 2025 in Review

Lindbrook Capital increased its GeneDx Holdings (WGS) stake by 144% in Q1 2025, buying an estimated $2K and bringing the position to 39 shares worth $3.45K. The position accounts for ﹤0.01% of the portfolio, ranked #2103.

Lindbrook Capital first reported a position in WGS in Q2 2024 and has held it in 4 quarters since. 225 funds tracked by Wall St. Rank hold WGS as of Q1 2025.

  • Lindbrook Capital held 39 shares of GeneDx Holdings worth $3.45K as of Q1 2025.
  • Lindbrook Capital bought 23 GeneDx Holdings shares in Q1 2025, an estimated $2K.
  • GeneDx Holdings made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2103 holding.
  • Lindbrook Capital first reported a position in GeneDx Holdings in Q2 2024 and has held it in 4 quarters since.
  • 225 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.